mk 0663 has been researched along with Adjuvant Arthritis in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Byun, Y; Choi, JK; Choi, YH; Chung, S; Jeong, YS; Kim, JK; Kim, JY; Koh, HJ; Lee, KW; Lim, KM; Moh, JH; Noh, MS; Oh, YI; Park, YH; Shin, SS | 1 |
Amat, M; Beleta, J; Cárdenas, A; Caturla, F; Crespo, MI; Godessart, N; Jiménez, JM; Ryder, H; Soca, L | 1 |
Beswick, P; Bingham, S; Bountra, C; Brown, T; Browning, K; Campbell, I; Chessell, I; Clayton, N; Collins, S; Corfield, J; Guntrip, S; Haslam, C; Lambeth, P; Lucas, F; Mathews, N; Murkit, G; Naylor, A; Pegg, N; Pickup, E; Player, H; Price, H; Stevens, A; Stratton, S; Wiseman, J | 1 |
Bressan, E; Tonussi, CR | 1 |
Andersen, ML; Schütz, TC; Tufik, S | 1 |
5 other study(ies) available for mk 0663 and Adjuvant Arthritis
Article | Year |
---|---|
In vitro structure-activity relationship and in vivo studies for a novel class of cyclooxygenase-2 inhibitors: 5-aryl-2,2-dialkyl-4-phenyl-3(2H)furanone derivatives.
Topics: Adult; Animals; Arthritis, Experimental; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Edema; Furans; Humans; In Vitro Techniques; Isoenzymes; Macrophages, Peritoneal; Male; Membrane Proteins; Mice; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Structure-Activity Relationship | 2004 |
Synthesis and biological evaluation of 2-phenylpyran-4-ones: a new class of orally active cyclooxygenase-2 inhibitors.
Topics: Administration, Oral; Animals; Arthritis, Experimental; Blood Proteins; Cyclooxygenase 2; Humans; Hyperalgesia; Isoenzymes; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Protein Binding; Pyrans; Rats; Rats, Wistar; Structure-Activity Relationship | 2004 |
Identification of 2,3-diaryl-pyrazolo[1,5-b]pyridazines as potent and selective cyclooxygenase-2 inhibitors.
Topics: Administration, Oral; Animals; Arthritis, Experimental; Biological Availability; Brain; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Freund's Adjuvant; Humans; Infusions, Intravenous; Male; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Pyridazines; Rats; Structure-Activity Relationship | 2004 |
Antiinflammatory effects of etoricoxib alone and combined with NSAIDs in LPS-induced reactive arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Carrageenan; Cyclooxygenase Inhibitors; Etoricoxib; Gastric Mucosa; Indomethacin; Knee Joint; Leukocytes; Lipopolysaccharides; Male; Pain Measurement; Piroxicam; Pyridines; Rats; Rats, Wistar; Sulfones; Synovial Fluid | 2008 |
Effects of COX-2 inhibitor in temporomandibular joint acute inflammation.
Topics: Acute Disease; Animals; Arthritis, Experimental; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Etoricoxib; Male; Prostaglandin D2; Pyridines; Random Allocation; Rats; Rats, Wistar; Sleep Wake Disorders; Sleep, REM; Sulfones; Temporomandibular Joint Disorders | 2007 |